Trial
NCT03866109
A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Genenta Science
Collaborators
—
Condition
Glioblastoma Multiforme
Intervention
Temferon
Why stopped
LVLP (pt GBM-01034) took place on 27may2026. The 2 remaining slots allocated by the protocol for the additional cohort to generate safety data prior to study Part B will not be filled. No safety concerns. Benefit-risk profile unchanged.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-11